: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
twins linus, left, and maarten have more sweat glands and tooth precursors than their older brother joshua, 5, after being treated with a drug in utero.
.
.
.
.
one thought on “chess grandmasters show the same longevity advantage as elite athletes”